title: Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?
abstract: The strongest known risk factors for late-onset Alzheimer disease (LOAD) remain a positive family history and the APOE epsilon4 allele. van Exel and colleagues used these known risk factors to identify high- and low-risk samples of middle-aged persons in whom they compared levels of inflammatory and vascular risk factors. They observed that, compared with controls, middle-aged offspring of families with a parental history of LOAD had higher blood pressures, lower ankle-brachial indices (measure of peripheral atherosclerosis), and increased production of proinflammatory cytokines in lipopolysaccharide-stimulated whole blood samples, associations that were independent of APOE genotype. This study adds to the growing body of evidence linking inflammatory mechanisms to Alzheimer disease risk and, especially when considered in light of the recently described association of genetic variation in the complement receptor 1 (CR1) gene with LOAD, suggests that inflammatory biomarkers (whether causal or incidental) could be measured and perhaps used to risk-stratify middle-aged persons for early preventive and therapeutic interventions.
authors.affiliation: Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Division of Aging in the Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 1620 Tremont Street, 3rd Floor, Boston, MA 02120, USA. ztan@hms.harvard.edu.
authors.forename: Zaldy S
authors.initials: ZS
authors.lastname: Tan
authors.forename: Sudha
authors.initials: S
authors.lastname: Seshadri
references.citation: J Alzheimers Dis. 2009;18(1):79-87
references.pmid: 19542629
references.citation: J Neurosci. 2001 Feb 15;21(4):1179-88
references.pmid: 11160388
references.citation: Neurol Clin. 2007 Aug;25(3):611-67, v
references.pmid: 17659183
references.citation: Neurology. 2003 Jul 8;61(1):76-80
references.pmid: 12847160
references.citation: FEBS Lett. 1994 Nov 14;354(3):289-92
references.pmid: 7957941
references.citation: JAMA. 2003 Jun 4;289(21):2819-26
references.pmid: 12783912
references.citation: Brain Res Mol Brain Res. 1992 Nov;16(1-2):128-34
references.pmid: 1334190
references.citation: Lancet Neurol. 2008 Jun;7(6):483-93
references.pmid: 18450517
references.citation: Brain Res. 1997 Feb 21;749(1):152-6
references.pmid: 9070642
references.citation: Neurology. 2007 May 29;68(22):1902-8
references.pmid: 17536046
references.citation: Nat Genet. 2009 Oct;41(10):1094-9
references.pmid: 19734903
references.citation: Ann N Y Acad Sci. 2004 Dec;1035:104-16
references.pmid: 15681803
references.citation: Neurosci Lett. 1994 Aug 15;177(1-2):23-6
references.pmid: 7824175
references.citation: Neurology. 2008 Jun 10;70(24):2291-8
references.pmid: 18509093
references.citation: Life Sci. 1992;51(25):1953-6
references.pmid: 1453878
references.citation: Neurology. 2007 Mar 27;68(13):1032-8
references.pmid: 17389308
references.citation: J Gerontol A Biol Sci Med Sci. 1999 Jul;54(7):M357-64
references.pmid: 10462168
references.citation: J Neurosci. 2003 Mar 1;23(5):1605-11
references.pmid: 12629164
references.citation: J Am Geriatr Soc. 2002 Dec;50(12):2041-56
references.pmid: 12473019
references.citation: N Engl J Med. 2001 Nov 22;345(21):1515-21
references.pmid: 11794217
references.citation: Arch Gen Psychiatry. 2009 Nov;66(11):1263-70
references.pmid: 19884614
references.citation: Epidemiology. 2006 Mar;17(2):183-9
references.pmid: 16477259
references.citation: J Neuroimmunol. 2000 Feb 1;103(1):97-102
references.pmid: 10674995